{"title":"Compliance of hypertensive patients with antihypertensive drug therapy at the Renaissance Hospital of N’Djamena, Chad","authors":"AA Ali, GM Abderraman, Z. Tondi, H. Mahamat","doi":"10.29328/journal.ach.1001019","DOIUrl":null,"url":null,"abstract":"High blood pressure is a major cardiovascular risk factor. It concerns more than 50% of the French population over 50 years of age [1]. Therapeutic compliance is a complex phenomenon and many authors have described various barriers to adherence that have been classi ied in ive dimensions by the World Health Organization: social/ economic, health system related, disease related, related to the treatment or to the patient [2,3]. In hypertensive patients, therapeutic compliance is de ined by the patient’s ability to comply with antihypertensive treatment and associated non-drug measures. This ability is in luenced positively or negatively by emotional, behavioral and social factors that interact with each other [4,5]. Chronic diseases requiring long-term treatment with many life-behavior changes that are associated with poor treatment adherence leading to deleterious effects for both the patient and the community. Abstract","PeriodicalId":90435,"journal":{"name":"Annals of clinical and experimental hypertension","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of clinical and experimental hypertension","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29328/journal.ach.1001019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
High blood pressure is a major cardiovascular risk factor. It concerns more than 50% of the French population over 50 years of age [1]. Therapeutic compliance is a complex phenomenon and many authors have described various barriers to adherence that have been classi ied in ive dimensions by the World Health Organization: social/ economic, health system related, disease related, related to the treatment or to the patient [2,3]. In hypertensive patients, therapeutic compliance is de ined by the patient’s ability to comply with antihypertensive treatment and associated non-drug measures. This ability is in luenced positively or negatively by emotional, behavioral and social factors that interact with each other [4,5]. Chronic diseases requiring long-term treatment with many life-behavior changes that are associated with poor treatment adherence leading to deleterious effects for both the patient and the community. Abstract